







Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YLR016C | PML1 | SGDID:S000004006 | MEK1 MRE4 YOR351C O6357 |
Meiosis-specific serine/threonine-protein kinase MEK1 (EC 2.7.11.1) |
2.7.11.1 | Saccharomyces cerevisiae | 5yyx_a | P24719 | 97.60 | 5.20E-08 | 4.20E-12 | 70.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YLR016C | PML1 | SGDID:S000004006 | DDL At3g20550 K10D20.9 |
FHA domain-containing protein DDL (Protein DAWDLE) |
Arabidopsis thaliana | 3vpy_a | Q8W4D8 | 98.80 | 1.40E-12 | 1.10E-16 | 97.10 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | PML1 YLR016C L1591 |
Pre-mRNA leakage protein 1 |
Saccharomyces cerevisiae | 3els_a | Q07930 | 99.50 | 1.20E-18 | 9.80E-23 | 133.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | CT_664 |
CT_664 |
Chlamydia trachomatis | 3gqs_a | O84671 | 98.10 | 8.80E-10 | 7.50E-14 | 74.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | Ppp1r8 Nipp1 |
Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8) |
Mus musculus | 2jpe_a | Q8R3G1 | 98.60 | 1.40E-11 | 1.20E-15 | 89.80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | garA Rv1827 MTCY1A11.16c |
Glycogen accumulation regulator GarA |
Mycobacterium tuberculosis | 2kfu_a | P9WJA9 | 98.60 | 1.10E-11 | 9.10E-16 | 93.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | APTX AXA1 |
Aprataxin (EC 3.6.1.71) (EC 3.6.1.72) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT) |
3.6.1.71,3.6.1.72, | Homo sapiens | Refsum Disease, Classic,Agnosia,Spinocerebellar Ataxia Type 1 With Axonal Neuropathy,Pontocerebellar Hypoplasia, Type 7,Spastic Ataxia, Charlevoix-Saguenay Type,Mitochondrial Dna Depletion Syndrome 7,Motor Peripheral Neuropathy,Oculomotor Apraxia,Choreatic Disease,Cerebellar Disease,Tay-Sachs Disease,Ataxia-Oculomotor Apraxia 3,Dystonia,Prostate Squamous Cell Carcinoma,Neuropathy,Peripheral Nervous System Disease,Cardiofaciocutaneous Syndrome 1,Vestibular Nystagmus,Ataxia With Vitamin 3 Deficiency,Autosomal Dominant Cerebellar Ataxia,Xeroderma Pigmentosum, Variant Type,Friedreich Ataxia,Disease Of Mental Health,Achalasia-Addisonianism-Alacrima Syndrome,Multiple Acyl-Coa Dehydrogenase Deficiency,Dentatorubral-Pallidoluysian Atrophy,Mental Retardation, X-Linked, With Cerebellar Hypoplasia And Distinctive Facial Appearance,Spinocerebellar Ataxia 14,Spinocerebellar Ataxia, Autosomal Recessive, With Axonal Neuropathy 2,Coenzyme Q10 Deficiency, Primary, 4,Coenzyme Q10 Deficiency Disease,Lig4 Syndrome,Marinesco-Sjogren Syndrome,Autosomal Recessive Cerebellar Ataxia,Hereditary Ataxia,Spastic Ataxia,Spastic Paraplegia 7, Autosomal Recessive,Coenzyme Q10 Deficiency, Primary, 1,Apraxia,Charcot-Marie-Tooth Disease, Axonal, Type 2cc,Ataxia-Telangiectasia,Ataxia, Early-Onset, With Oculomotor Apraxia And Hypoalbuminemia,Kearns-Sayre Syndrome,Ocular Motor Apraxia |
3kt9_a | Q7Z2E3 | ENSG00000137074 | APTX | 97.60 | 4.10E-08 | 3.50E-12 | 65.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YLR016C | PML1 | SGDID:S000004006 | DHX16 DBP2 DDX16 KIAA0577 PRP2 |
Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16) |
3.6.4.13 | Homo sapiens | Seizure Disorder,Neuromuscular Disease,Corpus Callosum, Agenesis Of,Intellectual Disability - Hypoplastic Corpus Callosum - Preauricular Tag,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Neuromuscular Oculoauditory Syndrome,Agenesis Of Corpus Callosum, Cardiac, Ocular, And Genital Syndrome |
5z56_x | O60231 | ENSG00000204560 | DHX16 | 99.70 | 6.20E-22 | 4.50E-26 | 170.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YLR016C | PML1 | SGDID:S000004006 | BQ2027_MB1858 |
Uncharacterized protein Mb1858 |
Mycobacterium bovis | 2kkl_a | P64898 | 97.70 | 2.00E-08 | 1.70E-12 | 72.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | Pnkp |
Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)] |
2.7.1.78,3.1.3.32, | Mus musculus | 1yj5_c | Q9JLV6 | 97.80 | 9.40E-09 | 7.70E-13 | 75.00 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YLR016C | PML1 | SGDID:S000004006 | Tb927.7.2480 |
Tb927.7.2480 |
Trypanosoma brucei | 2n84_a | Q57XM6 | 99.30 | 6.40E-16 | 5.20E-20 | 119.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | garA MSMEG_3647 MSMEI_3561 |
Glycogen accumulation regulator GarA |
Mycolicibacterium smegmatis | 6i2q_b | A0QYG2 | 97.70 | 1.80E-08 | 1.60E-12 | 69.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | DUN1 YDL101C D2370 |
DNA damage response protein kinase DUN1 (EC 2.7.11.1) |
2.7.11.1 | Saccharomyces cerevisiae | 2jql_a | P39009 | 97.70 | 2.20E-08 | 1.80E-12 | 73.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YLR016C | PML1 | SGDID:S000004006 | TIFA T2BP |
TRAF-interacting protein with FHA domain-containing protein A (Putative MAPK-activating protein PM14) (Putative NF-kappa-B-activating protein 20) (TRAF2-binding protein) |
Homo sapiens | Hepatocellular Carcinoma |
4zgi_a | Q96CG3 | ENSG00000145365 | TIFA | 97.60 | 4.20E-08 | 3.40E-12 | 71.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YLR016C | PML1 | SGDID:S000004006 | MDC1 KIAA0170 NFBD1 |
Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1) |
Homo sapiens | Cerebellar Disease,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Seckel Syndrome,Riddle Syndrome,Lig4 Syndrome,Renal Cell Carcinoma, Nonpapillary,Nijmegen Breakage Syndrome,Ataxia-Telangiectasia,Primary Autosomal Recessive Microcephaly |
3umz_a | Q14676 | ENSG00000137337 | MDC1 | 97.90 | 5.70E-09 | 4.90E-13 | 71.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YLR016C | PML1 | SGDID:S000004006 | RAD53 MEC2 SAD1 SPK1 YPL153C P2588 |
Serine/threonine-protein kinase RAD53 (EC 2.7.12.1) (CHEK2 homolog) (Serine-protein kinase 1) |
2.7.12.1 | Saccharomyces cerevisiae | 1fhq_a | P22216 | 98.10 | 1.50E-09 | 1.20E-13 | 81.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YLR016C | PML1 | SGDID:S000004006 | SNIP1 |
Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1) |
Homo sapiens | Epilepsy,Benign Epilepsy With Centrotemporal Spikes,Psychomotor Retardation, Epilepsy, And Craniofacial Dysmorphism |
6ff7_0 | Q8TAD8 | ENSG00000163877 | SNIP1 | 99.70 | 1.00E-21 | 7.60E-26 | 169.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YLR016C | PML1 | SGDID:S000004006 | VPS64 FAR9 YDR200C YD9346.10C |
Vacuolar protein sorting-associated protein 64 (Factor arrest protein 9) |
Saccharomyces cerevisiae | 6a8w_a | Q03944 | 97.90 | 7.50E-09 | 6.00E-13 | 75.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | RNF8 KIAA0646 |
E3 ubiquitin-protein ligase RNF8 (hRNF8) (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8) |
2.3.2.27 | Homo sapiens | Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Riddle Syndrome |
2csw_a | O76064 | ENSG00000112130 | RNF8 | 97.80 | 1.30E-08 | 1.10E-12 | 74.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YLR016C | PML1 | SGDID:S000004006 | odhI Cgl1441 cg1630 |
Oxoglutarate dehydrogenase inhibitor |
Corynebacterium glutamicum | 2kb4_a | Q8NQJ3 | 98.40 | 9.90E-11 | 8.20E-15 | 85.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | fhaA TB39.8 Rv0020c |
FHA domain-containing protein FhaA |
Mycobacterium tuberculosis | 2lc1_a | P71590 | 97.90 | 6.30E-09 | 5.40E-13 | 69.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | Mdc1 Kiaa0170 |
Mediator of DNA damage checkpoint protein 1 |
Mus musculus | 3va4_a | Q5PSV9 | 97.60 | 3.60E-08 | 3.00E-12 | 70.40 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | nbs1 SPBC6B1.09c |
DNA repair and telomere maintenance protein nbs1 |
Schizosaccharomyces pombe | 3huf_b | O43070 | 97.70 | 1.80E-08 | 1.50E-12 | 82.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | MKI67 |
Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67) |
Homo sapiens | Skin Melanoma,Cervical Intraepithelial Neoplasia,Neuroendocrine Tumor,Endometrial Cancer,Squamous Cell Carcinoma,Clear Cell Meningioma,Malignant Fibrous Histiocytoma,Endometrial Hyperplasia,Desmoid Tumor,Adenoma,Myxofibrosarcoma,Parathyroid Carcinoma,Adenosarcoma,Mucoepidermoid Carcinoma,Benign Meningioma,B-Cell Lymphoma,Oral Leukoplakia,Sinonasal Undifferentiated Carcinoma,Embryonal Sarcoma,Keratocystic Odontogenic Tumor,Brain Ependymoma,Congenital Mesoblastic Nephroma,Polymorphous Low-Grade Adenocarcinoma,Cavernous Hemangioma,Pulmonary Vein Stenosis,Leiomyoma,Basal Cell Carcinoma,Necrotizing Sialometaplasia,Transitional Cell Carcinoma,Bladder Cancer,Soft Tissue Sarcoma,Spitz Nevus,Leukoplakia,Breast Ductal Carcinoma,Breast Cancer,Colorectal Cancer,Hepatocellular Carcinoma,Ameloblastic Carcinoma,Keratoacanthoma,Inverted Papilloma,Spinal Cord Melanoma,Central Neurocytoma,Bowen'S Disease,Breast Disease,Prostate Cancer,Papillary Thyroid Microcarcinoma,Epithelioid Trophoblastic Tumor,Adrenal Cortical Carcinoma,Breast Fibroadenoma,Bladder Adenocarcinoma,Cervical Squamous Cell Carcinoma,Sarcoma, Synovial,Barrett Esophagus,Gastrointestinal Stromal Tumor,Inflammatory Myofibroblastic Tumor,Renal Cell Carcinoma, Nonpapillary,Meningioma, Familial,Ductal Carcinoma In Situ,Lung Cancer |
2aff_a | P46013 | ENSG00000148773 | MKI67 | 97.80 | 1.50E-08 | 1.30E-12 | 70.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YLR016C | PML1 | SGDID:S000004006 | SLC4A1AP HLC3 |
Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein) |
Homo sapiens | Laminopathy,Bare Lymphocyte Syndrome, Type I,Glycerol Kinase Deficiency |
4h87_b | Q9BWU0 | ENSG00000163798 | SLC4A1AP | 98.20 | 3.50E-10 | 3.00E-14 | 80.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YLR016C | PML1 | SGDID:S000004006 | Saci_1210 |
Saci_1210 |
Sulfolobus acidocaldarius | 5a8i_a | Q4J9H4 | 98.40 | 9.90E-11 | 8.00E-15 | 91.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YLR016C | PML1 | SGDID:S000004006 | RAD53 MEC2 SAD1 SPK1 YPL153C P2588 |
Serine/threonine-protein kinase RAD53 (EC 2.7.12.1) (CHEK2 homolog) (Serine-protein kinase 1) |
2.7.12.1 | Saccharomyces cerevisiae | 1dmz_a | P22216 | 99.00 | 4.80E-14 | 3.60E-18 | 107.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |